To establish the role of TXNIP and downstream genes HIF1α and IL1β in the biology of cRCC, we have applied immunohistochemistry to tissue multi-arrays containing tumours of patients without detectable metastases at the time of operation. This evidence concerns the gene IL1B and chromophobe renal cell carcinoma.